MDT - Medtronic Plc


80
-0.970   -1.213%

Share volume: 8,266,971
Last Updated: 05-01-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$80.97
-0.97
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
44%
Profitability 37%
Dept financing 21%
Liquidity 25%
Performance 62%
Company vs Stock growth
vs
Performance
5 Days
-3.52%
1 Month
-7.65%
3 Months
-22.11%
6 Months
-11.31%
1 Year
-5.72%
2 Year
-1.14%
Key data
Stock price
$80.00
P/E Ratio 
28.04
DAY RANGE
$79.97 - $81.17
EPS 
$3.59
52 WEEK RANGE
$78.91 - $106.33
52 WEEK CHANGE
-$4.13
MARKET CAP 
129.330 B
YIELD 
2.81%
SHARES OUTSTANDING 
1.284 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$9,561,402
AVERAGE 30 VOLUME 
$8,696,650
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news